Christine Poulin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Christine poulin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Christine Poulin Today - Breaking & Trending Today

Quebec immigration program only accepting French applicants

An immigration program designed for entrepreneurs will now only accept applications from French speakers in Quebec. It is part of the Coalition Avenir Quebec (CAQ) promise to have 100 per cent of newcomers to the province be francophone by 2026. ....

Christine Poulin , Winston Chan , Christine Frechette , Francois Legault , Coalition Avenir Quebec , Premier Francois Legault , French Speaking Quebec ,

Building a better future with biosimilars

Sponsored Content By Teva Canada Biologic medicines have been crucial in the treatment and prevention of diseases for over half a century. Though the benefits of biologic medicines are clear, Canadian consumers still face the obstacle of finding treatment options that are easily accessible and affordable. Biosimilars address this gap and provide additional treatment alternatives […] ....

Christine Poulin , Health Canada , Senior Vice President , General Manager , Teva Canada ,

Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults


Published: Apr 08, 2021
Teva Canada Announces New Autoinjector for AJOVY®
for the Preventive Treatment of Migraine in Adults
AJOVY®
now offers patients greater flexibility with two dosing options available in both an autoinjector and a prefilled syringe
AJOVY®
is the first and only subcutaneous anti-CGRP treatment with both quarterly (every three months) and monthly dosing options using either the autoinjector or prefilled syringe for the preventive treatment of migraine in adults.
AJOVY®
is supported by the AJOVY® Teva Support Solutions® (AJOVY® TSS) Patient Support Program, whose services include reimbursement navigation, bridging/copay coverage, and injection training.
AJOVY®
has been studied in patients with either chronic or episodic migraine and was shown to significantly reduce patients’ mean monthly migraine days with some patients achieving a 50% reduction or more. ....

United States , Christine Poulin , Elizabeth Leroux , Canadian Headache Society , Patient Support Program , Nj Teva Pharmaceuticals United States Inc , Teva Support Solutions , Teva Canada , Institute For Health Metrics , Teva Pharmaceutical Industries Ltd , Health Rep , European Union , Canada Limited , Business Wire , Support Solutions , Migraine Quebec , Patient Support , Novopharm Limited , Teva Caregiver , Teva Pharmaceutical Industries , Pharmaceutical Industries , Stock Keeping , Teva Canada Limited , Human Factor , Pharmaceuticals United States , Disease Study ,